Skip to main content
SpringerLink
Log in

Postoperative Adjuvant Therapy: Past, Present, and Future Trial Development

  • Chapter
Pancreatic Cancer

Part of the book series: M. D. Anderson Solid Tumor Oncology Series ((MDA))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cancer Statistics, 1999. CA Cancer J Clin. 1999;49(1):12–13.

    Google Scholar 

  2. Douglass H. Adjuvant therapy for pancreatic cancer. World J Surg. 1995;19:1701–1774.

    Article  Google Scholar 

  3. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993;165:68–73.

    CAS  PubMed  Google Scholar 

  4. Shibamoto Y, Manabe T, Baba M. High dose, external beam and introperative radiotherapy in the treatment of resectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 1990;19:605–611.

    CAS  PubMed  Google Scholar 

  5. Nitecki SS, Sarr MG, Colby TV, Van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg. 1995;221(1):59–66.

    CAS  PubMed  Google Scholar 

  6. Piorkowski RJ, Believernicht SW, Lawrence W. Jr. Pancreatic and periampullary carcinoma: experience with 200 patients over a 12-year period. Am J Surg. 1982;143:189–192.

    CAS  PubMed  Google Scholar 

  7. Gudjonsson B. Cancer of the pancreas: 50 years of surgery. Cancer. 1987;60:2284–2303.

    CAS  PubMed  Google Scholar 

  8. Trede M, Chir B, Schwall G, Saeger H-D. Survival after pancreaticoduodenectomy. Ann Surg. 1990;21(4):447–458.

    Google Scholar 

  9. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. Two hundred and one patients. Ann Surg. 1995;221(6):721–731.

    CAS  PubMed  Google Scholar 

  10. Gastrointestinal Tumor Study Group. Therapy of locally unresected pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads+5-Fluorouracil), and high dose radiation+5-Fluorouracil. Cancer. 1981;48:1705–1710.

    Google Scholar 

  11. Whittington R, Bryer MP, Haller DG, Solin LJ, Rosato EF. Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 1991;21:1137–1143.

    CAS  PubMed  Google Scholar 

  12. Tepper J, Nardi G, Suit H. Carcinoma of the pancreas: review of MGH experience from 1963 to 1973—analysis of surgical failure and implications for radiation therapy. Cancer. 1976;37:1519–1524.

    CAS  PubMed  Google Scholar 

  13. Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 1985;12:899–903.

    Google Scholar 

  14. Douglass HO, Strablein DM. Ten year follow-up of first generation surgical adjuvant studies of the Gastrointestinal Tumor Study Group. In: Salmon SE, ed. Adjuvant Therapy of Cancer. Vol 4. Philadelphia, Pa: WB Saunders; 1990:405–415.

    Google Scholar 

  15. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 1987;59:2006–2010.

    Google Scholar 

  16. Bakkevold KE, Arnesjo B, Dahl O, Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater—results of a controlled, prospective, randomized multicentre study. Eur J Cancer. 1993;29A(5):698–703.

    CAS  PubMed  Google Scholar 

  17. Klinkenbijl JHG, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-Fluorouracil after curative resection of cancer of the pancreas and periampullary region—phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg. 1999;230(6):776–784.

    Article  CAS  PubMed  Google Scholar 

  18. Simon RM. Design and analysis of clinic trials. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1997:513–528.

    Google Scholar 

  19. Amano H, Takada T, Kato H. Five-year results of a randomized study of postoperative adjuvant chemotherapy for resected pancreatic-biliary carcinomas. Proceed ASCO. 1999;18:273a (#1049).

    Google Scholar 

  20. Neoptolemos JP, Kerr DJ, Beger H, et al. ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer. Digestion. 1997;58:570–577.

    CAS  PubMed  Google Scholar 

  21. Foo ML, Gunderson LL, Nagorney DM, et al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation+5-Fluorouracil. Int J Radiat Oncol Biol Phys. 1993;26:483–489.

    CAS  PubMed  Google Scholar 

  22. Mohiuddin M, Rosato F, Schuricht A, Barbot D, Biermann W, Cantor R. Carcinoma of the pancreas—the Jefferson experience 1975–1988. Eur J Surg Oncol. 1994;20:13–20.

    CAS  PubMed  Google Scholar 

  23. Yeo CJ, Hruban RH, Kern SE, et al. Adenocarcinomas of the pancreas; factors influencing outcome after pancreaticoduodenectomy—the John Hopkins experience. Cancer Bull. 1994;46(6):504–510.

    Google Scholar 

  24. Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. Ann Surg. 1997;225(5):621–636.

    Article  CAS  PubMed  Google Scholar 

  25. Haller DG, Mayer RJ, Gunderson LL, et al. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. New Engl J Med. 1994;331(8):502–507.

    PubMed  Google Scholar 

  26. Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol. 1997;15(3):928–937.

    CAS  PubMed  Google Scholar 

  27. Whittington R, Neuberg D, Tester WJ, Benson AB III, Haller DG. Protracted intravenous fluorouracil infusion with radiation therapy management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Group trial. J Clin Oncol. 1995;13:227–232.

    CAS  PubMed  Google Scholar 

  28. Burris HA, Moore MJ, Anderson J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15(6):2403–2413.

    CAS  PubMed  Google Scholar 

  29. Rothenberg ML, Moore MJ, Cripps MC, et al. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol. 1996;7:347–353.

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. William F. Regine
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA

    Douglas B. Evans M.D. (Professor of Surgery) & Peter W. T. Pisters M.D., F.A.C.S. (Associate Professor of Surgery) (Professor of Surgery) &  (Associate Professor of Surgery)

  2. Department of Gastrointestinal Medical Oncology, The University Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA

    James L. Abbruzzese M.D. (Professor of Medical Oncology, Chairman) (Professor of Medical Oncology, Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Regine, W.F. (2002). Postoperative Adjuvant Therapy: Past, Present, and Future Trial Development. In: Evans, D.B., Pisters, P.W.T., Abbruzzese, J.L. (eds) Pancreatic Cancer. M. D. Anderson Solid Tumor Oncology Series. Springer, New York, NY. https://doi.org/10.1007/0-387-21600-6_20

Download citation

  • DOI: https://doi.org/10.1007/0-387-21600-6_20

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95185-0

  • Online ISBN: 978-0-387-21600-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation